- Home
- PBYI vs TCX Comparison
PBYI vs TCX Comparison
Compare PBYI & TCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- TCX
- Stock Information
- Founded
- PBYI 2010
- TCX 1992
- Country
- PBYI United States
- TCX Canada
- Employees
- PBYI N/A
- TCX N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- TCX EDP Services
- Sector
- PBYI Health Care
- TCX Technology
- Exchange
- PBYI Nasdaq
- TCX Nasdaq
- Market Cap
- PBYI 153.2M
- TCX 179.0M
- IPO Year
- PBYI N/A
- TCX 1996
- Fundamental
- Price
- PBYI $2.92
- TCX $17.05
- Analyst Decision
- PBYI Strong Buy
- TCX
- Analyst Count
- PBYI 1
- TCX 0
- Target Price
- PBYI $7.00
- TCX N/A
- AVG Volume (30 Days)
- PBYI 416.5K
- TCX 48.4K
- Earning Date
- PBYI 11-07-2024
- TCX 11-07-2024
- Dividend Yield
- PBYI N/A
- TCX N/A
- EPS Growth
- PBYI 492.79
- TCX N/A
- EPS
- PBYI 0.47
- TCX N/A
- Revenue
- PBYI $243,569,000.00
- TCX $356,135,000.00
- Revenue This Year
- PBYI N/A
- TCX $8.16
- Revenue Next Year
- PBYI N/A
- TCX N/A
- P/E Ratio
- PBYI $6.26
- TCX N/A
- Revenue Growth
- PBYI 6.30
- TCX 7.50
- 52 Week Low
- PBYI $2.23
- TCX $15.01
- 52 Week High
- PBYI $7.73
- TCX $28.66
- Technical
- Relative Strength Index (RSI)
- PBYI 47.45
- TCX 46.42
- Support Level
- PBYI $2.82
- TCX $15.64
- Resistance Level
- PBYI $3.12
- TCX $18.78
- Average True Range (ATR)
- PBYI 0.20
- TCX 0.88
- MACD
- PBYI -0.03
- TCX -0.02
- Stochastic Oscillator
- PBYI 14.71
- TCX 39.72
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About TCX Tucows Inc.
Tucows Inc is a corporate parent, allocating capital and providing efficient shared services to its three businesses. The Company offers Mobile Service Enabler (MSE) solutions, as well as professional services to other retail mobile providers. The Company is also a distributor of Internet services, including domain name registration, digital certificates, and email. It provides these services through an Internet-based distribution network of Internet Service Providers, web hosting companies, and other providers of Internet services to end-users. It operates in three segments: Ting, Wavelo, and Tucows Domains. It generates the majority of its revenue from Tucows Domains.